Because our group aspires to achieve the rational design of antineoplastic and antimicrobial agents (18, [21] [22] , the crystallographic investigation reported here provides the first opportunity to compare the detailed structures of human and prokaryotic NMN adenylyltransferases. Based on structural similarities identified on the basis of the Methanococcus jannaschii structure, previously solved by our group (18), NMNAT was recognized to be a member of the nucleotidyltransferase superfamily of α/β phosphodiesterases. Characterized by the presence of a highly conserved H/TXGH motif (19) , these enzymes share a common adenylylation mechanism. We have now determined the crystal structure of recombinant human NMN adenylyltransferase in its free form at a resolution of 2.5 Å. The structure reveals an hexameric assembly with 322 symmetry composed of α/β topology subunits. The enzyme active site has been analyzed through a detailed structural comparison with M. jannaschii (18) and M. thermoautotrophicum
EXPERIMENTAL PROCEDURES
Crystallization-The recombinant protein used in the crystallization experiments was purified from Escherichia coli as previously described and consists of a polypeptide chain of 279 residues (14) . The protein was provided in a buffered solution containing 0.02 M Tris at pH 8.0, 2 mM ATP and 2 mM MgCl 2 and has proven to be active. Crystals of human NMNAT were grown using the hanging drop vapor diffusion method, by equilibrating 2µl purified protein solution at a concentration of 20 mg/ml, against an equal volume of reservoir solution containing 1.8 M ammonium sulfate, 0.1 M Tris pH=8.1, 4% v/v isopropanol.
The crystals grow to a size of approximately 0.1 x 0.1 x 0.1 mm, in about 4-5 days at 20 °C and can be assigned to two different space groups depending on the cryoprotectant employed for data collection at 100 K. If 20% glycerol is used, the analysis of the diffraction data sets collected allowed us to assign the NMNAT crystals to the monoclinic space group P21 (crystal form I) with cell dimensions a=141.0 Å, b=87.0 Å c=141.9 Å, β=118.10°, containing six molecules per asymmetric unit with a corresponding solvent content of 70%.
For crystal form I a diffraction limit of 3.3 Å resolution, was observed. On the other hand, when light paraffin oil is employed as a cryoprotectant, NMNAT crystals belong to the hexagonal space group P6 3 22 (crystal form II) with cell dimensions a=b=147.50 Å, c=61.50 Å and diffract to 2.5 Å resolution. In this case one molecule is present per asymmetric unit with a corresponding solvent content of 60%.
Structure solution and refinement-For data collection and heavy atom screening, the crystals were transferred in a stabilizing solution containing 2.0 M ammonium sulfate, 0.1 M Tris pH=8.1, 4% v/v isopropanol, 2mM ATP and 2mM MgCl 2 . All data sets were collected using synchrotron radiation at the beam line ID14 EH3 at ESRF (Grenoble, France, λ=0,8139 Å ) at a temperature of 100 K. Diffraction data sets employed for SIR phasing were collected on the monoclininc crystals, whereas the high resolution data set employed in refinement was collected on the hexagonal crystals. Diffracted intensities were evaluated and integrated using the program MOSFLM (23) , while the CCP4 suite was used for data reduction (24) . Table I gives a summary of the data collection statistics. The mercuric chloride isomorphous difference Patterson map was solved using SHELX-90 (25) and heavy atom parameters were refined using MLPHARE (26) ; phasing statistics are reported in Table   I . The soaking time for the mercuric derivative was 6 hours at a concentration of 0.5 mM.
The initial SIR electron density map calculated for the monoclinic crystal form did not allow chain tracing, providing only a clear identification of the protein boundaries. The initial SIR phases were then sensibly improved by means of 6-fold density averaging. The presence of an hexamer with 32 point group symmetry in the asymmetric unit , was confirmed through the calculation of the self-rotation function, performed using the program AmoRe (27) attempted. An envelope was defined on the basis of the polyalanine model built in the monoclinic structure (covering one monomer), whereas the starting electron density was derived from the initial SIR phases. The calculation was carried out with the program DMMULTI (29) , extending the phases for the hexagonal crystal form to 2.5 Å resolution.
The resulting electron density map was of high quality and an unambiguous tracing including all the side chains, was performed using the program O (30). Nevertheless three major breaks were present in the electron density map, between residues 1-4,111-147 and 258-279.
Only the hexagonal structure was subjected to refinement because of the highest resolution obtained using these crystals. The crystallographic refinement was carried out at 2.5 Å employing REFMAC (31) . A random sample containing 965 reflections (roughly 1% of the total number of reflections) was excluded from the refinement and used for the calculation of the "free" R-factor (32) . The program O was used for manual rebuilding of the model. The initial model (80% of the whole molecule) was subjected to 10 cycles of rigid body refinement in the 15.0 -4.0 Å resolution range, lowering the R-factor and the R-free to 39% and 41%, respectively. Subsequently, 50 cycles of REFMAC were performed, observing a drop of the crystallographic R-factor to 34% (free R-factor 36%). Additional 50 cycles of refinement were carried out, obtaining a R-factor and a free R-factor of 26% and 28%, respectively. Solvent molecules were manually added at positions with density > 4σ in the Fo-Fc map, considering only peaks engaged in at least one hydrogen bond with protein atom or solvent atom. A final round of 20 cycles of refinement was carried out on the resulting model until convergence, at a R factor of 23.4% and Rfree of 28.1%.
The current model contains 216 amino acid residues and 58 water molecules. The three major breaks detected after the multicrystal density averaging procedure were still present in the refined electron density map, between residues 1-4,111-147 and 258-279.
These breaks in the electron density were also present in all the six subunits of the monoclinic structure. The average B-factor for the 1750 protein atoms and for the 58 ordered water molecules are 58.7 Å 2 and 56.2 Å 2 (54.6 Å 2 for the main chain and 62.7 Å 2 for the side chains), respectively. The results of refinement are summarized in Table I .
Deposition-Coordinates of human NMNAT have been deposited with the
Brookhaven Protein Data Bank (accession code 1KKU). Overall structure-The polypeptide chain of each NMNAT folds into six β-strands, nine α-helices and connecting loops. The protein architecture consists of a classical α/β dinucleotide binding domain (residues 5-216), whose core is a strongly twisted 6-stranded parallel open β-sheet, flanked on both sides by α-helices (Figure 1 ). The C-terminal portion of the protein (residues 217-258) forms a second small domain, made up by two α-helices ( Figure 1 ). An hexameric assembly was observed in both the two crystal forms. In the hexagonal crystal form, the 322 crystallographic symmetry operations assemble the monomers present in the asymmetric unit into an hexamer (Figures 2a,2b) . The same oligomeric arrangement is observed in the monoclinic crystal form, where an hexamer endowed with 32 point group symmetry, is present in the asymmetric unit.
RESULTS AND DISCUSSION

Overall
The overall quaternary structure can be viewed as a trimer-of-dimers, where two major intersubunit interfaces can be distinguished. The first concerns associated protomers related by a dyad axis (Figures 2a,2b) , whereas the second involves protomers related by a three-fold axis (Figure 2a) . A total of 2100 Å 2 molecular surface are buried upon oligomerization on each monomer. In particular, 1200 Å 2 of the accessible surface are buried on each monomer upon dimer formation. Many interactions occurring across the dyad axis participate in dimer stabilization, including hydrogen bonds and hydrophobic contacts.
Residues 217-220 meet their equivalent in the facing monomer, and residues 234-238 of one subunit contact residues 26-33 of the other (Figure 3 ). Phe217 appears to play an important role in the dimer stabilization making a strong hydrophobic interaction with Ile221 of the other monomer ( Figure 3 ). Interestingly, a single nucleotide polymorphism was reported for human NMNAT, resulting in the expression of either phenylalanine or leucine at position 217 (34). In our structure, a phenylalanine residues occupies the position 217 ( Figure 3 ).
However, the presence of a leucine residue would be fully compatible with the structural environment observed, and would not disrupt the network of hydrophobic interaction essential for the dimer stability.
Fewer contacts are observed between protomers related by the triad axis where 500
The approximate overall dimensions of the globular hexamer of human NMNAT are 60 Å along the triad axis and 50 Å across it. As can be seen in figure 2a a NMNAT was reported by us to be a tetramer in solution, based on gel filtration experiments (14) . Therefore, the crystallographic observed hexamer could not represent the only functionally active oligomeric state for NMNAT. In this respect, the dimer builiding up the hexamer ( Figure 3 ) could be considered as the minimal NMNAT oligomeric unit resulting in tetramers or hexamers, depending on the environmental conditions.
Consistent with its sub-cellular localization, a putative nuclear localization signal was identified in the human enzyme in the 123PGRKRKW129 amino acids stretch (12) .
Moreover, a previously proposed interaction with PARP1 (35) has recently been confirmed (12) , stressing a possible role of NMNAT in regulating PARP1 activity. Despite NMNAT was proven to be a substrate for nuclear kinases in vitro (12) , either which of the proposed putative residues (positions 109, 136 and 256) is actually phosphorylated, or weather the phosphorylated form has a precise physiological role, is still unknown (12) . However, is tempting to speculate for a possible role of phosphorylation in regulating either the enzyme activity or the interaction with PARP1. In this respect, it should be noticed that both the putative phosphorylation sites and the nuclear localization signal are disordered in our structure ( Figure 1) . We speculate that a conformational change may occur upon phosphorylation and/or formation of a protein-protein complex with PARP1, resulting in the structuration of the flexible regions.
Comparison with the human enzyme's active-site with those of other NMN
adenylyltransferases-The catalytic mechanism of this key enzyme has been investigated in depth, showing a kinetic behavior fully compatible with an ordered sequential Bi-Bi mechanism (36). According to the proposed mechanism NMN binds first followed by ATP, and in the reversed reaction PPi precedes NAD. Once both NMN and ATP are bound to the enzyme's active site, the reaction proceeds through a nucleophilic attack by the 5' phosphate of NMN on the α-phosphoryl of ATP, assisted by a magnesium ion which plays an essential role in catalysis (9,18).
We cannot presently obtain diffracting crystals of enzyme complexed with any of its Despite not strictly conserved Thr21 is a key residue for ATP recognition (Figures 5,6 ). In fact, Thr21 would contact the ATP β-phopshate, analogously to the His16 in the M.
jannaschii NMNAT-ATP complex (18), therefore appearing as an important residue for ATP binding. Moreover, as already reported for glutaminyl-tRNA synthetase (47), PPAT (43) and M. jannaschii NMNAT (18) the main chain nitrogen atom of Thr21 is hydrogen bonded to the δ-nitrogen of His24 which is therefore neutral, with a proton localized on its ε-nitrogen.
Such a remarkable conservation of the hydrogen bonding scheme for the residues part of the T/HXXH motif, strongly support the notation of a relevant role in catalysis for the second conserved histidine supposed to stabilize the transition state intermediate. With respect to ATP binding, as much as important appear to be the role played by Thr224 and Arg227, both strictly conserved in all NMNATs ( Figure 5 ). The two residues are part of the (222)SXTXXR(227) sequence, which is structurally conserved in all NMNATs (Figures 5,   6 ). Both the threonine and arginine residues were reported to stabilize the ATP γ-phosphate in the structure of M. jannaschii NMNAT-ATP complex (18). Moreover, the SXTXXR motif is localized at the N-terminus of the H8 helix (Figures 1, 4) , a conserved secondary structural element in NMNATs, which was suggested to participate in ATP recognition through the interaction of its dipole with the ATP β-phosphate in the M. jannaschii-ATP complex (18). On the other hand, none of the residues contacting the ATP α-and β-phosphates in the M. jannaschii NMNAT-ATP complex are conserved in the human enzyme.
Particularly interesting is the absence in the human enzyme of a highly conserved arginine residue contacting the ATP β-phosphate in all nucleotidyltransferases, which was suggested to be a key residue for ATP recognition in nucleotidyltransferases (18, 39, 43, 47) . 
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